AI-powered medical search engine that delivers synthesized, cited answers from peer-reviewed research for clinicians.
AI Medical Technology
$1Starting price
0Popularity
About AI Medical Technology
AI Medical Technology develops AI-driven diagnostic solutions for healthcare, with a focus on skin cancer evaluation. Its primary product, Dermalyser, serves as a decision-support tool for clinicians, enabling faster and more precise analysis of skin conditions. The platform is designed to assist dermatologists, general practitioners, and oncology specialists by providing diagnostic suggestions that enhance accuracy and reduce unnecessary procedures. By integrating with existing electronic health records, Dermalyser streamlines workflows and supports timely treatment planning. The tool is particularly valuable in settings where specialist access is limited, offering a cost-effective alternative to traditional diagnostic methods. Regular updates ensure alignment with advancements in AI and healthcare standards, while robust data security measures protect sensitive patient information.
Key features
- AI-powered diagnostics for skin cancer detection
- Clinically validated decision support tool
- User-friendly interface for healthcare professionals
- Integration with electronic health records (EHR)
- Multi-device compatibility for flexible usage
- Adherence to healthcare data protection regulations
- Continuous updates to maintain accuracy and relevance
- Cost-effective solution reducing unnecessary procedures
Use cases
- Dermatologists using the tool for accurate skin cancer diagnosis
- General practitioners assessing skin anomalies in primary care
- Healthcare institutions training medical students in dermatological diagnostics
Pros
- CE-marked medical device certified under EU MDR 2017/745 for regulatory compliance
- Provides AI-driven decision support with 96% AUC accuracy in skin lesion assessment
- Reduces unnecessary procedures and referrals through precise diagnostic suggestions
- Offers immediate feedback during consultations, enhancing workflow efficiency
- Designed in collaboration with dermatologists and primary care physicians for clinical relevance
Cons
- Requires a compatible dermatoscope and smartphone for image capture, limiting use to equipped settings
- Final diagnosis remains with the healthcare professional, meaning AI serves as a support tool rather than a standalone solution
Frequently asked questions about AI Medical Technology
What is Dermalyser?
Dermalyser is a CE-marked software that uses artificial intelligence to analyze digital dermatoscopic images of skin lesions. It functions as a decision-support tool for healthcare professionals when assessing suspected skin melanomas.
Who is allowed to use Dermalyser?
Only licensed healthcare professionals, such as general practitioners, primary care physicians, and dermatologists, are permitted to use Dermalyser.
Does Dermalyser replace a dermatologist?
No. Dermalyser is a decision-support tool. The final diagnosis is always made by healthcare professionals.
What do I need to use Dermalyser?
A smartphone with the Dermalyser app, a compatible dermatoscope, and a clinical environment with trained healthcare staff are required to use Dermalyser.
Is Dermalyser certified for medical use?
Yes, Dermalyser is a CE-marked medical device certified under EU MDR 2017/745, ensuring compliance with European medical device regulations.
How is Dermalyser integrated into clinical workflows?
Dermalyser provides immediate AI-driven analysis of dermatoscopic images during consultations, offering faster diagnoses and reducing the need for external expert opinions.
